{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:16:08Z","timestamp":1790972168604,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2023-MS-265"],"award-info":[{"award-number":["2023-MS-265"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s12072-023-10621-x","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T09:02:12Z","timestamp":1704531732000},"page":"188-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Lin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangning","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-0719","authenticated-orcid":false,"given":"Qiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,6]]},"reference":[{"key":"10621_CR1","doi-asserted-by":"publisher","first-page":"830532","DOI":"10.3389\/fphar.2022.830532","volume":"13","author":"M Guo","year":"2022","unstructured":"Guo M, et al. Dracocephalum tanguticumextracts of maxim ameliorate acute alcoholic liver disease regulating transcription factors in mice. Front Pharmacol. 2022;13:830532","journal-title":"Front Pharmacol"},{"issue":"2","key":"10621_CR2","doi-asserted-by":"publisher","first-page":"11020182","DOI":"10.3390\/cells11020182","volume":"11","author":"R Mainz","year":"2022","unstructured":"Mainz R, et al. NLRP6 inflammasome modulates disease progression in a chronic-plus-binge mouse model of alcoholic liver disease. Cells. 2022;11(2):11020182","journal-title":"Cells"},{"key":"10621_CR3","doi-asserted-by":"publisher","first-page":"107752","DOI":"10.1016\/j.pharmthera.2020.107752","volume":"222","author":"B Wen","year":"2021","unstructured":"Wen B, et al. Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways. Pharmacol Ther. 2021;222:107752","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10621_CR4","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1136\/gutjnl-2017-315123","volume":"68","author":"M Heo","year":"2019","unstructured":"Heo M, et al. Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression. Gut. 2019;68(4):708\u2013720","journal-title":"Gut"},{"issue":"4","key":"10621_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","volume":"12","author":"A Louvet","year":"2015","unstructured":"Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015;12(4):231\u2013242","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10621_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.taap.2018.08.019","volume":"357","author":"J Sun","year":"2018","unstructured":"Sun J, et al. Nrf2 in alcoholic liver disease. Toxicol Appl Pharmacol. 2018;357:62\u201369","journal-title":"Toxicol Appl Pharmacol"},{"issue":"8","key":"10621_CR7","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.7150\/thno.40149","volume":"10","author":"Y Li","year":"2020","unstructured":"Li Y, et al. NIK links inflammation to hepatic steatosis by suppressing PPAR\u03b1 in alcoholic liver disease. Theranostics. 2020;10(8):3579\u20133593","journal-title":"Theranostics"},{"key":"10621_CR8","doi-asserted-by":"publisher","first-page":"117237","DOI":"10.1016\/j.jep.2023.117237","volume":"319","author":"P Rao","year":"2023","unstructured":"Rao P, et al. Prunella vulgaris L. attenuates gut dysbiosis and endotoxin leakage against alcoholic liver disease. J Ethnopharmacol. 2023;319:117237","journal-title":"J Ethnopharmacol"},{"key":"10621_CR9","doi-asserted-by":"publisher","first-page":"877650","DOI":"10.3389\/fimmu.2022.877650","volume":"13","author":"M Hu","year":"2022","unstructured":"Hu M, et al. viaD-mannose regulates hepatocyte lipid metabolism PI3K\/Akt\/mTOR signaling pathway and ameliorates hepatic steatosis in alcoholic liver disease. Front Immunol. 2022;13:877650","journal-title":"Front Immunol"},{"issue":"3","key":"10621_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/path.2888","volume":"224","author":"F Rangwala","year":"2011","unstructured":"Rangwala F, et al. Increased production of sonic hedgehog by ballooned hepatocytes. J Pathol. 2011;224(3):401\u2013410","journal-title":"J Pathol"},{"issue":"5","key":"10621_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","volume":"81","author":"B Forman","year":"1995","unstructured":"Forman B, et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell. 1995;81(5):687\u2013693","journal-title":"Cell"},{"issue":"51","key":"10621_CR12","doi-asserted-by":"publisher","first-page":"e2213041119","DOI":"10.1073\/pnas.2213041119","volume":"119","author":"T Fu","year":"2022","unstructured":"Fu T, et al. FXR mediates ILC-intrinsic responses to intestinal inflammation. Proc Natl Acad Sci USA. 2022;119(51):e2213041119","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"10621_CR13","doi-asserted-by":"publisher","first-page":"12966","DOI":"10.1039\/D2FO02341E","volume":"13","author":"S Ma","year":"2022","unstructured":"Ma S, et al. viaThe protective effects of sulforaphane on high-fat diet-induced metabolic associated fatty liver disease in mice mediating the FXR\/LXR\u03b1 pathway. Food Funct. 2022;13(24):12966\u201312982","journal-title":"Food Funct"},{"issue":"1","key":"10621_CR14","doi-asserted-by":"publisher","first-page":"18873","DOI":"10.1038\/s41598-022-23539-5","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, et al. Effect of FXR agonist GW4064 in the treatment of hilar cholangiocarcinoma in rats. Sci Rep. 2022;12(1):18873","journal-title":"Sci Rep"},{"key":"10621_CR15","doi-asserted-by":"publisher","first-page":"738689","DOI":"10.3389\/fphar.2021.738689","volume":"12","author":"Z Cui","year":"2021","unstructured":"Cui Z, et al. Allium victorialis L. extracts promote activity of FXR to ameliorate alcoholic liver disease: targeting liver lipid deposition and inflammation. Front Pharmacol. 2021;12:738689","journal-title":"Front Pharmacol"},{"issue":"2","key":"10621_CR16","doi-asserted-by":"publisher","first-page":"113781","DOI":"10.1016\/j.yexcr.2023.113781","volume":"432","author":"Z Xu","year":"2023","unstructured":"Xu Z, et al. Dimethyl fumarate attenuates cholestatic liver injury by activating the NRF2 and FXR pathways and suppressing NLRP3\/GSDMD signaling in mice. Exp Cell Res. 2023;432(2):113781","journal-title":"Exp Cell Res"},{"key":"10621_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1262-3636(08)74605-6","volume":"34","author":"B Cariou","year":"2008","unstructured":"Cariou B. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis. Diabetes Metab. 2008;34:685\u2013691","journal-title":"Diabetes Metab"},{"key":"10621_CR18","first-page":"1","volume":"2023","author":"H Jiang","year":"2023","unstructured":"Jiang H, et al. Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD\/ASC stability via selective autophagy to alleviate tendinopathy. Autophagy. 2023;2023:1\u201318","journal-title":"Autophagy"},{"issue":"4","key":"10621_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/exd.14711","volume":"32","author":"T Cao","year":"2023","unstructured":"Cao T, et al. Neutrophil extracellular traps promote keratinocyte inflammation via AIM2 inflammasome and AIM2-XIAP in psoriasis. Exp Dermatol. 2023;32(4):368\u2013378","journal-title":"Exp Dermatol"},{"issue":"13","key":"10621_CR20","doi-asserted-by":"publisher","first-page":"23137447","DOI":"10.3390\/ijms23137447","volume":"23","author":"C Rossi","year":"2022","unstructured":"Rossi C, et al. The P2X7R-NLRP3 and AIM2 inflammasome platforms mark the complexity\/severity of viral or metabolic liver damage. Int J Mol Sci. 2022;23(13):23137447","journal-title":"Int J Mol Sci"},{"issue":"18","key":"10621_CR21","doi-asserted-by":"publisher","first-page":"21186535","DOI":"10.3390\/ijms21186535","volume":"21","author":"B Lozano-Ruiz","year":"2020","unstructured":"Lozano-Ruiz B, Gonz\u00e1lez-Navajas J. The emerging relevance of AIM2 in liver disease. Int J Mol Sci. 2020;21(18):21186535","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10621_CR22","doi-asserted-by":"publisher","first-page":"152875","DOI":"10.1016\/j.prp.2020.152875","volume":"216","author":"C Chen","year":"2020","unstructured":"Chen C, et al. The hepatoprotective effects of XCHD and MgIG against methotrexate-induced liver injury and inflammation in rats through suppressing the activation of AIM2 inflammasomes. Pathol Res Pract. 2020;216(4):152875","journal-title":"Pathol Res Pract"},{"issue":"6","key":"10621_CR23","doi-asserted-by":"publisher","first-page":"G1034","DOI":"10.1152\/ajpgi.00431.2020","volume":"320","author":"L Xu","year":"2021","unstructured":"Xu L, et al. Mitochondrial DNA enables AIM2 inflammasome activation and hepatocyte pyroptosis in nonalcoholic fatty liver disease. Am J Physiol Gastrointestinal Liver Physiol. 2021;320(6):G1034\u2013G1044","journal-title":"Am J Physiol Gastrointestinal Liver Physiol"},{"issue":"6","key":"10621_CR24","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.apsb.2021.03.038","volume":"11","author":"L Ding","year":"2021","unstructured":"Ding L, et al. Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice. Acta pharmaceut Sin B. 2021;11(6):1541\u20131554","journal-title":"Acta pharmaceut Sin B"},{"issue":"3","key":"10621_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.arcmed.2023.02.004","volume":"54","author":"J Valencia-Ortega","year":"2023","unstructured":"Valencia-Ortega J, et al. Differential expression of FXR and genes involved in inflammation and lipid metabolism indicate adipose tissue dysfunction in gestational diabetes. Arch Med Res. 2023;54(3):189\u2013196","journal-title":"Arch Med Res"},{"key":"10621_CR26","doi-asserted-by":"publisher","first-page":"668708","DOI":"10.3389\/fphar.2021.668708","volume":"12","author":"J Chu","year":"2021","unstructured":"Chu J, et al. Sinapic acid reduces oxidative stress and pyroptosis via inhibition of BRD4 in alcoholic liver disease. Front Pharmacol. 2021;12:668708","journal-title":"Front Pharmacol"},{"key":"10621_CR27","doi-asserted-by":"publisher","first-page":"105594","DOI":"10.1016\/j.phrs.2021.105594","volume":"168","author":"R Yan","year":"2021","unstructured":"Yan R, et al. Ubiquitin-specific protease 22 ameliorates chronic alcohol-associated liver disease by regulating BRD4. Pharmacol Res. 2021;168:105594","journal-title":"Pharmacol Res"},{"issue":"9","key":"10621_CR28","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jpha.2023.05.012","volume":"13","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, et al. Eight Zhes Decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics, network pharmacology and pharmacokinetics. J Pharmaceut Anal. 2023;13(9):1058\u20131069","journal-title":"J Pharmaceut Anal"},{"issue":"9","key":"10621_CR29","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jpha.2023.05.005","volume":"13","author":"J Zou","year":"2023","unstructured":"Zou J, et al. Ginsenoside Rk2, a dehydroprotopanaxadiol saponin, alleviates alcoholic liver disease via regulating NLRP3 and NLRP6 inflammasome signaling pathways in mice. J Pharmaceut Anal. 2023;13(9):999\u20131012","journal-title":"J Pharmaceut Anal"},{"key":"10621_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2020.03.031","volume":"153","author":"J Kai","year":"2020","unstructured":"Kai J, et al. Oroxylin a promotes PGC-1\u03b1\/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease. Free Radical Biol Med. 2020;153:89\u2013102","journal-title":"Free Radical Biol Med"},{"key":"10621_CR31","first-page":"e075179","volume":"383","author":"M Romero-G\u00f3mez","year":"2023","unstructured":"Romero-G\u00f3mez M, et al. Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention. BMJ (Clin Res Ed). 2023;383:e075179","journal-title":"BMJ (Clin Res Ed)"},{"issue":"9","key":"10621_CR32","first-page":"670","volume":"21","author":"Y Hu","year":"2023","unstructured":"Hu Y, et al. Puerarin inhibits inflammation and lipid accumulation in alcoholic liver disease through regulating MMP8. Chin J Nat Med. 2023;21(9):670\u2013681","journal-title":"Chin J Nat Med"},{"issue":"1","key":"10621_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12602-022-10005-x","volume":"15","author":"H Liu","year":"2023","unstructured":"Liu H, et al. Compound probiotic ameliorates acute alcoholic liver disease in mice by modulating gut microbiota and maintaining intestinal barrier. Probiot Antimicrob Proteins. 2023;15(1):185\u2013201","journal-title":"Probiot Antimicrob Proteins"},{"key":"10621_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pharmthera.2017.06.007","volume":"180","author":"M Xu","year":"2017","unstructured":"Xu M, et al. Targeting inflammation for the treatment of alcoholic liver disease. Pharmacol Ther. 2017;180:77\u201389","journal-title":"Pharmacol Ther"},{"issue":"13","key":"10621_CR35","first-page":"1","volume":"12","author":"S Yang","year":"2023","unstructured":"Yang S, et al. Ginsenoside Rh4 improves hepatic lipid metabolism and inflammation in a model of NAFLD by targeting the gut liver axis and modulating the FXR signaling pathway. Foods (Basel, Switzerland). 2023;12(13):1","journal-title":"Foods (Basel, Switzerland)"},{"issue":"3","key":"10621_CR36","doi-asserted-by":"publisher","first-page":"166320","DOI":"10.1016\/j.bbadis.2021.166320","volume":"1868","author":"B Jiang","year":"2022","unstructured":"Jiang B, et al. Prevotella copri ameliorates cholestasis and liver fibrosis in primary sclerosing cholangitis by enhancing the FXR signalling pathway. Biochim Biophys Acta Mol Basis Dis. 2022;1868(3):166320","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"34","key":"10621_CR37","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1021\/acs.jafc.1c04035","volume":"69","author":"Y Li","year":"2021","unstructured":"Li Y, et al. Novel \u03b9-carrageenan tetrasaccharide alleviates liver lipid accumulation via the bile acid-FXR-SHP\/PXR pathway to regulate cholesterol conversion and fatty acid metabolism in insulin-resistant mice. J Agric Food Chem. 2021;69(34):9813\u20139821","journal-title":"J Agric Food Chem"},{"issue":"20","key":"10621_CR38","doi-asserted-by":"publisher","first-page":"7723","DOI":"10.1021\/acs.jafc.3c00952","volume":"71","author":"C Zhang","year":"2023","unstructured":"Zhang C, et al. Dietary isoquercetin reduces hepatic cholesterol and triglyceride in NAFLD mice by modulating bile acid metabolism via intestinal FXR-FGF15 signaling. J Agric Food Chem. 2023;71(20):7723\u20137733","journal-title":"J Agric Food Chem"},{"issue":"5","key":"10621_CR39","doi-asserted-by":"publisher","first-page":"7103","DOI":"10.1096\/fj.201903244R","volume":"34","author":"M Song","year":"2020","unstructured":"Song M, et al. Hyodeoxycholic acid (HDCA) suppresses intestinal epithelial cell proliferation through FXR-PI3K\/AKT pathway, accompanied by alteration of bile acids metabolism profiles induced by gut bacteria. FASEB J Off Publ Federation Am Soc Exp Biol. 2020;34(5):7103\u20137117","journal-title":"FASEB J Off Publ Federation Am Soc Exp Biol"},{"issue":"2","key":"10621_CR40","doi-asserted-by":"publisher","first-page":"22020872","DOI":"10.3390\/ijms22020872","volume":"22","author":"M Sharma","year":"2021","unstructured":"Sharma M, de Alba E. Structure, activation and regulation of NLRP3 and AIM2 inflammasomes. Int J Mol Sci. 2021;22(2):22020872","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10621_CR41","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/1878-0261.12090","volume":"11","author":"S Chen","year":"2017","unstructured":"Chen S, et al. HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis. Mol Oncol. 2017;11(9):1225\u20131240","journal-title":"Mol Oncol"},{"key":"10621_CR42","doi-asserted-by":"publisher","first-page":"102322","DOI":"10.1016\/j.redox.2022.102322","volume":"52","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. Overexpression of NAG-1\/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation. Redox Biol. 2022;52:102322","journal-title":"Redox Biol"},{"issue":"18","key":"10621_CR43","doi-asserted-by":"publisher","first-page":"15184025","DOI":"10.3390\/nu15184025","volume":"15","author":"B Zhang","year":"2023","unstructured":"Zhang B, Niu L, Huang X. Lonicera caerulea juice alleviates alcoholic liver disease by regulating intestinal flora and the FXR-FGF15 signaling pathway. Nutrients. 2023;15(18):15184025","journal-title":"Nutrients"},{"key":"10621_CR44","first-page":"153629","volume":"90","author":"L Kong","year":"2021","unstructured":"Kong L, et al. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR. Phytomed Int J Phytother Phytopharmacol. 2021;90:153629","journal-title":"Phytomed Int J Phytother Phytopharmacol"},{"issue":"2","key":"10621_CR45","doi-asserted-by":"publisher","first-page":"23020774","DOI":"10.3390\/ijms23020774","volume":"23","author":"Y Yang","year":"2022","unstructured":"Yang Y, Cho Y, Hwang S. Crosstalk between oxidative stress and inflammatory liver injury in the pathogenesis of alcoholic liver disease. Int J Mol Sci. 2022;23(2):23020774","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10621_CR46","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/hep.22222","volume":"47","author":"Y Lu","year":"2008","unstructured":"Lu Y, et al. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology (Baltimore, MD). 2008;47(5):1483\u20131494","journal-title":"Hepatology (Baltimore, MD)"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-023-10621-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T15:01:33Z","timestamp":1730991693000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-023-10621-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,6]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10621"],"URL":"https:\/\/doi.org\/10.1007\/s12072-023-10621-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,6]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Qiang Meng, Lin Li, Lina Kong, Shuai Xu, Changyuan Wang, Jiangning Gu and Haifeng Luo declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the institution at which the studies were conducted and ethical approval was obtained from the Ethics Committee of the Animal Protection and Use Committee of Dalian Medical University (Dalian, China). This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}